The India biopsy devices market reached a value of US$ 71.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 111.1 Million by 2027, exhibiting a CAGR of 7.59% during 2022-2027, according to IMARC Group’s latest report.
Year Considered to Estimate the Market Size:
Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027
A biopsy device refers to various medical equipment used for the removal of unwanted tissues that may lead to the production of carcinogen cells. Some of the commonly used biopsy devices are aspiration needles, forceps, and localization wires. These devices are primarily used in MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, core and vacuum-assisted biopsies, etc. As a result, biopsy devices are widely adopted across medical clinics, diagnostic centers, and hospitals.
Covid-19 Scenario:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/india-biopsy-devices-market/requestsample
Market Trends and Drivers:
The growing prevalence of chronic oncological ailments, such as lung cancer, breast cancer, colorectal cancer, ovarian cancer, etc., is propelling the demand for biopsy devices in India. Moreover, the rising number of diagnostic laboratories in the country is also augmenting the market growth. Additionally, the increasing demand for minimally-invasive surgeries, along with the growing penetration of disposable biopsy devices, is further catalyzing the market in India. The rising investments in extensive R&D activities for the development of technologically-advanced products, such as vacuum-assisted guns and smart biopsy systems, are expected to further drive the market growth in the coming years.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Ask An Analyst – https://www.imarcgroup.com/request?type=report&id=3211&flag=C
The report has segmented the market on the basis of procedure type, product, application, guidance technique, end user and region.
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Region:
- North India
- West and Central India
- South India
- East India
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
